Transparency, health equity, and strategies in state-based protocols for remdesivir allocation and use.
<h4>Background</h4>The Emergency Use Authorization (EUA) of remdesivir for coronavirus disease 2019 raised questions on transparency of applied strategy, and how to equitably allocate and prioritize eligible patients given limited supply of the medication. The absence of federal oversigh...
Saved in:
Main Authors: | Zippora Kiptanui, Sanchari Ghosh, Sabeen Ali, Karishma Desai, Ilene Harris |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a8266d8db6ee432ea9b7af4b6e7d49bd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Equity Gaps in Education: Nine Points toward More Transparency
by: Albert Ziegler, et al.
Published: (2021) -
Evaluation of the United States COVID-19 vaccine allocation strategy.
by: Md Rafiul Islam, et al.
Published: (2021) -
Evaluation of the United States COVID-19 vaccine allocation strategy
by: Md Rafiul Islam, et al.
Published: (2021) -
Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus
by: Travis K. Warren, et al.
Published: (2021) -
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
by: Goran Kokic, et al.
Published: (2021)